Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy-Reference-Cited by-同舟云学术

Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy

Published:2020-10 Issue:4 Volume:53 Page:824-839.e10
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Weulersse Marianne,Asrir Assia,Pichler Andrea C.,Lemaitre Lea,Braun Matthias,Carrié Nadège,Joubert Marie-Véronique,Le Moine Marie,Do Souto Laura,Gaud Guillaume,Das Indrajit,Brauns Elisa,Scarlata Clara M.^ORCID,Morandi Elena^ORCID,Sundarrajan Ashmitha,Cuisinier Marine,Buisson Laure^ORCID,Maheo Sabrina,Kassem Sahar^ORCID,Agesta Arantxa,Pérès Michaël,Verhoeyen Els,Martinez Alejandra,Mazieres Julien^ORCID,Dupré Loïc,Gossye Thomas,Pancaldi Vera^ORCID,Guillerey Camille,Ayyoub Maha^ORCID,Dejean Anne S.^ORCID,Saoudi Abdelhadi^ORCID,Goriely Stanislas^ORCID,Avet-Loiseau Hervé,Bald Tobias^ORCID,Smyth Mark J.,Martinet Ludovic^ORCID

Funder

Cancer Research Institute

National Health and Medical Research Council

Ligue Contre le Cancer

Institut National Du Cancer

European Molecular Biology Organization

Fondation ARC pour la Recherche sur le Cancer

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference79 articles.